HC
RDUS

Henshaw Capital’s Radius Health, Inc. RDUS Stock Holding History

Henshaw Capital’s Portfolio RDUS Stock Details RDUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5,718
Closed -$221K – 337
2017
Q1 		$221K Buy
+5,718
New +$240K 0.02% 261

Other funds holding RDUS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Henshaw Capital's RDUS Position: Q2 2017 in Review

Henshaw Capital sold out of Radius Health, Inc. (RDUS) in Q2 2017, closing a stake of 5,718 shares — an estimated $221K sold.

Henshaw Capital first reported a position in RDUS in Q1 2017 and held it in 1 quarter. The position peaked at $221K in Q1 2017. 151 funds tracked by Wall St. Rank hold RDUS as of Q2 2017.

  • Henshaw Capital reported no remaining Radius Health, Inc. position as of Q2 2017 after selling out during the quarter.
  • Henshaw Capital sold 5,718 Radius Health, Inc. shares in Q2 2017, an estimated $221K.
  • Henshaw Capital first reported a position in Radius Health, Inc. in Q1 2017 and held it in 1 quarter.
  • Henshaw Capital's Radius Health, Inc. position peaked at $221K in Q1 2017.
  • 151 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q2 2017.

Based on Henshaw Capital's 13F filing for Q2 2017, filed 28 May 2026.